Please find enclosed disclosure

3rd September, 2026 (1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th floor, Dalal Street, Plot no. C/1, G Block, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg Sub: Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, Pursuant to the provisions of Regulation 30 of SEBI Listing Regulations and further to our intimation dated 19th August, 2026, we hereby notify that, in compliance with the order passed by the Hon’ble National Company Law Tribunal, Mumbai Bench ("NCLT") on 18th August, 2026, the notices (as enclosed), together with a copy of the Scheme and NCLT Order are being sent to the Company’s shareholders and creditors through electronic mode wherever e-mail addresses are available and through physical mode to the remaining shareholders and creditors. The aforesaid notice provides an opportunity to the shareholders and creditors to convey their representations, if any, in connection with the proposed Scheme to the Hon’ble NCLT within 30 (thirty) days from the date of receipt of the notice, with a copy thereof to the Company at its Registered Office. In the event no representation is received by the Hon’ble NCLT within the aforesaid period, it will be presumed that the concerned shareholder or creditor has no objection to the proposed Scheme. Kindly take the above information on record. Thanking you, Yours faithfully, For Cipla Limited Rajendra Chopra Company Secretary Prepared by: Chirag Hotchandani Encl: As above Cipla Ltd. Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Number L24239MH1935PLC002380 Cipla Limited Registered Office : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013 Phone : (9122) 41916000, Email : cosecretary@cipla.com, Website : www.cipla.com Corporate Identity Number : L24239MH1935PLC002380 Date: 3rd September, 2026 Dear Equity Shareholders, Notice is hereby given in pursuance of sub-section (5) of Section 230 of the Companies Act, 2013 and as directed by the Mumbai Bench of the Hon'ble National Company Law Tribunal ('NCLT' or 'Tribunal') by an order dated 18th August, 2026 under sub-section (1) of Section 230 of the Companies Act, 2013 ('the Act') in relation to the Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited ("Transferor Company") with Cipla Limited ("Transferee Company") and their respective shareholders ("Scheme"). Hon'ble NCLT in terms of order passed for directions in C.A. (CAA)/ 114 (MB)/ 2026 dated 18th August, 2026 ("NCLT Order") has dispensed with the meetings of the equity shareholders and unsecured creditors of the Transferee Company. However, as per NCLT Order, a notice is being sent to all the shareholders and unsecured creditors of the Transferee Company, informing them that they may submit their representations, if any, in respect of the proposed Scheme to the Hon'ble NCLT within 30 days of the receipt of the Notice. As there are no Secured Creditors in the Transferee Company, no meeting of Secured Creditors is required. Notice under section 230(5), copy of the NCLT Order and the Scheme can be accessed / downloaded from the Company's website using the following links: Notice under section 230(5) |Copy of NCLT Order | Scheme of Amalgamation You are hereby informed that representations, if any, in connection with the proposed Scheme may be made to the Hon'ble NCLT within 30 (thirty) days from the date of receipt of this notice, with a copy of the representation sent simultaneously to the Transferee Company at its Registered Office at Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013. If no response is received by the Hon'ble Tribunal within the stated period of 30 (thirty) days, it will be presumed that you have no objection to the proposed Scheme. Thanking you, Yours sincerely, For Cipla Limited Sd/- Rajendra Chopra Company Secretary ICSI Membership No: A12011 Cipla Limited Registered Office : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013 Phone : (9122) 41916000, Email : cosecretary@cipla.com, Website : www.cipla.com Corporate Identity Number : L24239MH1935PLC002380 Date: 3rd September, 2026 Dear Unsecured Creditors, Notice is hereby given in pursuance of sub-section (5) of Section 230 of the Companies Act, 2013 and as directed by the Mumbai Bench of the Hon’ble National Company Law Tribunal (‘NCLT’ or ‘Tribunal’) by an order dated 18th August, 2026 under sub-section (1) of Section 230 of the Companies Act, 2013 (‘the Act’) in relation to the Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited (“Transferor Company”) with Cipla Limited (“Transferee Company”) and their respective shareholders (“Scheme”). Hon’ble NCLT in terms of order passed for directions in C.A. (CAA)/ 114 (MB)/ 2026 dated 18th August, 2026 (“NCLT Order”) has dispensed with the meetings of the equity shareholders and unsecured creditors of the Transferee Company. However, as per NCLT Order, a notice is being sent to all the shareholders and unsecured creditors of the Transferee Company, informing them that they may submit their representations, if any, in respect of the proposed Scheme to the Hon'ble NCLT within 30 days of the receipt of the Notice. As there are no Secured Creditors in the Transferee Company, no meeting of Secured Creditors is required. Notice under section 230(5), copy of the NCLT Order and the Scheme can be accessed / downloaded from the Company’s website using the following links: Notice under section 230(5) | Copy of NCLT Order | Scheme of Amalgamation You are hereby informed that representations, if any, in connection with the proposed Scheme may be made to the Hon’ble NCLT within 30 (thirty) days from the date of receipt of this notice, with a copy of the representation sent simultaneously to the Transferee Company at its Registered Office at Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013. If no response is received by the Hon’ble Tribunal within the stated period of 30 (thirty) days, it will be presumed that you have no objection to the proposed Scheme. Thanking you, Yours sincerely, For Cipla Limited Sd/- Rajendra Chopra Company Secretary & Compliance Officer